Skip to content
Home » Astellas withdraws lawsuit challenging Medicare drug price negotiation plans

Astellas withdraws lawsuit challenging Medicare drug price negotiation plans

    The U.S. government, late last month, selected the first 10 drugs, including the top-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer, which will face price negotiations as part of President Joe Biden's Inflation Reduction Act. Several analysts had expected Astellas' prostate cancer drug to be part of the list.

    Read full NASCAR article on Yahoo Sports

    Read all NASCAR articles